Notable companies
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Bristol-Myers Squibb Co (NYSE:BMY).
Industry description
The investment seeks to provide long-term capital appreciation.
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Market Cap
The average market capitalization across the JPMorgan Healthcare Leaders ETF ETF is 80.17B. The market cap for tickers in the group ranges from 1.28B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is ROG at 1.28B.
High and low price notable news
The average weekly price growth across all stocks in the JPMorgan Healthcare Leaders ETF ETF was 13%. For the same ETF, the average monthly price growth was 32%, and the average quarterly price growth was 69%. IQV experienced the highest price growth at 11%, while ISRG experienced the biggest fall at -5%.
Volume
The average weekly volume growth across all stocks in the JPMorgan Healthcare Leaders ETF ETF was -24%. For the same stocks of the ETF, the average monthly volume growth was -4% and the average quarterly volume growth was 0%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 55
P/E Growth Rating: 68
Price Growth Rating: 56
SMR Rating: 61
Profit Risk Rating: 65
Seasonality Score: 32 (-100 ... +100)